BHP Approves $1.5 Bln CapEx For Phase 1 Of Scarborough Project

BHP (BHP.AX,BLT.L,BBL,BHP) announced Monday that it has approved $1.5 billion in capital expenditure for development of the Scarborough upstream project located in the North Carnarvon Basin, Western Australia.

The decision comes along with BHP's share sale agreement with Woodside Petroleum Ltd to merge their respective oil and gas portfolios.

The company noted that final investment decisions have also been made by Woodside and the Scarborough Joint Venture.

A $150 million payment is payable to BHP Petroleum (North West Shelf) Pty Ltd by Woodside upon the financial investment decision or FID of the Scarborough project pursuant to the 2016 divestment of BHP's 25 percent Scarborough Joint Venture interest to Woodside.

The approved capital expenditure represents BHP's 26.5 percent participating interest in Phase 1 of the upstream development. Woodside holds the remaining 73.5 percent interest and is the operator of the project.

On completion of the proposed merger, BHP shareholders will benefit from exposure to the fully integrated value chain of both the upstream project and the downstream Pluto LNG processing facilities due to their approximate 48 percent shareholding in Woodside.

For comments and feedback contact: editorial@rttnews.com

Business News

Editors Pick
This Black Friday and the following holiday season, retailers across the United States are urged to keep up their inventory amid expected surge in shopping as majority of Americans wait till last minute to fill their baskets, according to certain studies. A new Oracle Retail survey, which was conducted last week and presented earlier this week, showed that 66 percent of consumers were less than Eagle, Idaho -based Flagship Food Group is recalling certain TJ Farms Select brand frozen cauliflower, citing the potential to be contaminated with Listeria monocytogenes, the U.S. Food and Drug Administration said. The recall involves a limited number of cases of TJ Farms Select cauliflower that comes in 16 oz. packages with lot code 2077890089 and UPC code 75544000604-3. The U.S. Food and Drug Administration has approved Takeda Pharmaceuticals Co. Ltd.'s Livtencity (maribavir) as the first drug to treat post-transplant cytomegalovirus or CMV in adults and pediatric patients. The approval is to treat patients 12 years of age and older and weighing at least 35 kilograms with post-transplant CMV infection/disease that does not respond...
Follow RTT